Ford Kathryn, Paul Anu, Harrison Phillip, Davenport Mark
Department of Paediatric Surgery, King's College Hospital, Denmark Hill, London, United Kingdom.
Institute of Liver Studies, King's College Hospital, Denmark Hill, London, United Kingdom.
Eur J Pediatr Surg. 2016 Jun;26(3):232-9. doi: 10.1055/s-0035-1551565. Epub 2015 May 19.
Introduction Chronic pancreatitis (CP) can be a cause of recurrent, severe, disabling abdominal pain in children. Surgery has been suggested as a useful therapy, although experience is limited and the results unpredictable. We reviewed our experience of a two-stage protocol-preliminary endoscopic retrograde cholangiopancreatography (ERCP) and duct stenting, and if symptoms resolved, definitive surgical decompression by longitudinal pancreatojejunostomy (LPJ) (Puestow operation). Patients and Methods This is a single-center, retrospective review of children with established CP who underwent an LPJ between February 2002 and September 2012. A questionnaire was completed (incorporating visual analog scale pain and lifestyle scores) to assess functional outcome. Data are expressed as median (range). Results In this study, eight (M:F ratio of 4:4) children underwent an LPJ and one female child had a more limited pancreatojejunostomy anastomosis following preliminary ERCP and stent placement where possible. Diagnoses included hereditary pancreatitis (n = 3), idiopathic or structural pancreatitis (n = 5), and duct stricture following radiotherapy (n = 1). Median duct diameter presurgery was 5 (4-11) mm. Endoscopic placement of a Zimmon pancreatic stent was possible in six with relief of symptoms in all. Median age at definitive surgery was 11 (range, 7-17) years with a median postoperative stay of 9 (range, 7-12) days and a follow-up of 6 (range, 0.5-12) years. All children reported markedly reduced episodes of pain postprocedure. One developed diabetes mellitus, while three had exocrine deficiency (fecal elastase < 200 µg/g) requiring enzyme supplementation. The child with limited LPJ had symptomatic recurrence and required restenting and further surgery to widen the anastomosis to become pain free. Conclusion ERCP and stenting provide a therapeutic trial to assess possible benefit of a definitive duct drainage procedure. LPJ-the modified Puestow operation was safe and complication-free with good medium-term relief of symptoms. We were not able to identify a consistent etiology-associated outcome.
引言 慢性胰腺炎(CP)可能是儿童反复出现严重致残性腹痛的原因。手术已被认为是一种有效的治疗方法,尽管经验有限且结果难以预测。我们回顾了我们采用两阶段方案的经验——初步内镜逆行胰胆管造影(ERCP)和导管支架置入术,如果症状缓解,则通过纵向胰空肠吻合术(LPJ)(普斯托手术)进行确定性手术减压。
患者与方法 这是一项对2002年2月至2012年9月期间接受LPJ的确诊CP儿童进行的单中心回顾性研究。完成了一份问卷(包括视觉模拟评分疼痛和生活方式评分)以评估功能结局。数据以中位数(范围)表示。
结果 在本研究中,8名儿童(男女比例为4:4)接受了LPJ,1名女童在可能的初步ERCP和支架置入术后进行了更有限的胰空肠吻合术。诊断包括遗传性胰腺炎(n = 3)、特发性或结构性胰腺炎(n = 5)以及放疗后导管狭窄(n = 1)。术前导管直径中位数为5(4 - 11)mm。6例患者可行Zimmon胰管支架内镜置入术,所有患者症状均缓解。确定性手术时的中位年龄为11岁(范围7 - 17岁),术后中位住院时间为9天(范围7 - 12天),随访6年(范围0.5 - 12年)。所有儿童术后疼痛发作次数均明显减少。1例发生糖尿病,3例有外分泌功能不全(粪便弹性蛋白酶<200 µg/g)需要补充酶。LPJ有限的患儿出现症状复发,需要重新置入支架并进一步手术扩大吻合口以缓解疼痛。
结论 ERCP和支架置入术为评估确定性导管引流手术的可能益处提供了一种治疗性试验。LPJ——改良的普斯托手术安全且无并发症,中期症状缓解良好。我们未能确定与病因相关的一致结局。